SCHEMBL28120634

SCHEMBL28120634

N#CCCN(c1ccc(-c2cccc3cnc(Nc4cccc(CN5CCOCC5)c4)nc23)cc1)[SH](=O)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 2/20 0.53
▸ KDR P35968 2/20 0.53
▸ JAK3 P52333 4/20 0.47
▸ JAK2 O60674 3/20 0.47
▸ PTK2 Q05397 2/20 0.47
▸ MAPK10 P53779 1/20 0.44
▸ TBK1 Q9UHD2 4/20 0.43
▸ NTRK1 P04629 2/20 0.43
▸ CSF1R P07333 2/20 0.43
▸ TYK2 P29597 2/20 0.43
▸ NUAK1 O60285 1/20 0.43
▸ STK16 O75716 1/20 0.43
▸ CSNK2A2 P19784 1/20 0.43
▸ AAK1 Q2M2I8 1/20 0.43
▸ ULK3 Q6PHR2 1/20 0.43
▸ BMP2K Q9NSY1 1/20 0.43
▸ PDCD1 Q15116 1/20 0.42
▸ CD274 Q9NZQ7 1/20 0.42
▸ ACVR1 Q04771 1/20 0.41
▸ IKBKE Q14164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28674130 0.93 CDK1 (0.54) CDK1KDRJAK3JAK2PTK2
SCHEMBL28673294 0.90 JAK3 (0.51) CDK1KDRJAK3JAK2PTK2
SCHEMBL28120721 0.88 TTK (0.49) JAK3JAK2PTK2MAPK10TYK2
SCHEMBL28120642 0.86 CDK1 (0.52) CDK1KDRJAK3JAK2PTK2
SCHEMBL28678996 0.84 JAK2 (0.50) CDK1KDRJAK3JAK2PTK2
SCHEMBL18376757 0.82 CDK1 (0.52) CDK1KDRJAK3JAK2PTK2
SCHEMBL18377059 0.82 CDK1 (0.51) CDK1KDRJAK3JAK2PTK2
SCHEMBL18377058 0.81 JAK2 (0.59) CDK1KDRJAK3JAK2PTK2
SCHEMBL28695538 0.80 TBK1 (0.49) KDRJAK3JAK2PTK2MAPK10
SCHEMBL18376853 0.79 JAK3 (0.58) CDK1KDRJAK3JAK2PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN claimed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 — — CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 — — CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 — — CN disclosed
CN-106316965-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2017-01-11 — — CN disclosed
Send feedback